Tax cut won’t mitigate high prices for cancer, rare diseases medicines, say patient advocacy groups
Photo used for illustration purpose only. | Photo Credit: Getty Images/iStockphoto The recent Union Budget announcement provided custom duty waiver to 36 exorbitantly priced cancer and rare diseases drugs, but patient advocacy groups…